tetano
Editor, Senior Moderator
Mol Biol Rep
. 2021 Apr 23.
doi: 10.1007/s11033-021-06358-1. Online ahead of print.
Silent hypoxia in COVID-19: pathomechanism and possible management strategy
Ahsab Rahman[SUP] 1 [/SUP], Tahani Tabassum[SUP] 1 [/SUP], Yusha Araf[SUP] 2 [/SUP], Abdullah Al Nahid[SUP] 3 [/SUP], Md Asad Ullah[SUP] 4 [/SUP], Mohammad Jakir Hosen[SUP] 5 [/SUP]
Affiliations
Abstract
The novel coronavirus disease 2019 (COVID-19) has become a severe health issue, especially to the patients who develop silent hypoxia condition after SARS-CoV-2 infection. Due to the lack of dyspnoea and extremely low oxygen saturation level, these patients are at exceptionally higher risk. Although the prevalence of silent hypoxia in COVID-19 patients has been evident in several cases, the underlying pathomechanism behind this condition is still unclear. Silent hypoxia in SARS-CoV-2 infected patients can be diagnosed with the help of a pulse oximeter, blood gas levels, and a 6-min walking test. While the clinicians and researchers figure out the exact reason for this phenomenon, the patients must be under strict day-to-day monitoring. In this article, we aim to provide comprehensive insights into the underlying symptoms, mechanism, and possible factors behind the occurrence of silent hypoxia among COVID-19 patients.
Keywords: COVID-19; Dyspnoea; Management; Pathomechanism; Silent hypoxia.
. 2021 Apr 23.
doi: 10.1007/s11033-021-06358-1. Online ahead of print.
Silent hypoxia in COVID-19: pathomechanism and possible management strategy
Ahsab Rahman[SUP] 1 [/SUP], Tahani Tabassum[SUP] 1 [/SUP], Yusha Araf[SUP] 2 [/SUP], Abdullah Al Nahid[SUP] 3 [/SUP], Md Asad Ullah[SUP] 4 [/SUP], Mohammad Jakir Hosen[SUP] 5 [/SUP]
Affiliations
- PMID: 33891272
- DOI: 10.1007/s11033-021-06358-1
Abstract
The novel coronavirus disease 2019 (COVID-19) has become a severe health issue, especially to the patients who develop silent hypoxia condition after SARS-CoV-2 infection. Due to the lack of dyspnoea and extremely low oxygen saturation level, these patients are at exceptionally higher risk. Although the prevalence of silent hypoxia in COVID-19 patients has been evident in several cases, the underlying pathomechanism behind this condition is still unclear. Silent hypoxia in SARS-CoV-2 infected patients can be diagnosed with the help of a pulse oximeter, blood gas levels, and a 6-min walking test. While the clinicians and researchers figure out the exact reason for this phenomenon, the patients must be under strict day-to-day monitoring. In this article, we aim to provide comprehensive insights into the underlying symptoms, mechanism, and possible factors behind the occurrence of silent hypoxia among COVID-19 patients.
Keywords: COVID-19; Dyspnoea; Management; Pathomechanism; Silent hypoxia.